Back to mobile site

Lucid Capital Markets Upgrades INmune Bio Inc. (INMB) to Buy, 'Factoring in RDEB'

March 11, 2026 6:03 AM EDT Send to a Friend
(Updated - March 11, 2026 6:05 AM EDT)

Lucid Capital Markets analyst Elemer Piros upgraded INmune Bio Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login